biotech · Coronary Artery Disease · Bronchopulmonary Dysplasia · ASBP
Aspire Biopharma Holdings
Aspire Biopharma Holdings clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Humacao, USA HQ
2019 Founded
Public company Type
ASBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Humacao, USA
- Founded
- 2019
- Programs
- 8
- Drugs
- 8
- Patents
- 1
Aspire Biopharma Holdings projects
2 ClinicalTrials.gov programs sponsored by Aspire Biopharma Holdings.
Aspire Biopharma Holdings has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Aspire Biopharma Holdings have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.